Home » Topics » Regulatory

Regulatory
RSS

Zadaxin shows efficacy in preclinical invasive aspergillosis study

March 3, 2004

Alvesco receives first approval in Australia

March 2, 2004

Avastin approved for first-line metastatic colorectal cancer

March 1, 2004

Gonal-f prefilled pen receives European approval

Feb. 27, 2004

NovoSeven approved in Europe for factor VII deficiency and thrombasthenia

Feb. 23, 2004

Alimta approved for use with cisplatin for malignant pleural mesothelioma

Feb. 9, 2004

Caduet receives FDA approval

Feb. 5, 2004

European submission for YM-617 TOCAS

Feb. 4, 2004

Fabrazyme approved in Japan

Feb. 3, 2004

New regulatory submissions for Nexium

Feb. 2, 2004

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...